Inventprise
PrivateLast Round
Series A
May 4, 2023
Total Funding Raised
$115.83M
Company Overview
Inventprise is a biotechnology company that develops high-valency vaccines for infectious diseases using proprietary linker conjugation technology and automated manufacturing processes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inventprise Comparables
Compare Inventprise with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GSK plc | 80% | |
| GPN Vaccines | 79% | |
| Vaxcyte | 79% |
Inventprise Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 4, 2023 | ||||
| Grant | Apr 7, 2022 | ||||
| VC Round | Nov 10, 2021 | ||||
| Grant | Mar 1, 2021 | ||||
| Debt | Jun 3, 2020 | ||||
Grant | Mar 1, 2020 |
Key People
Founding team and executive leadership
Inventprise Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant, Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
76 employees impacted according to state filing.
- May 15, 2025
Developing an RSV vaccine as a proof of concept.
Inventprise Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Inventprise's valuation, stock price, and market status.
Is Inventprise a public or private company?
Inventprise is a private company.
What is the current stock price of Inventprise?
Inventprise is a private company with no public stock price. No recent secondary market data is available.
How much is Inventprise worth (valuation)?
Valuation information for Inventprise is not publicly available.
Can I buy Inventprise stock?
Inventprise shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Inventprise's last funding round?
Inventprise's most recent funding round was Series A on May 4, 2023.
Who are the main investors in Inventprise?
Key investors in Inventprise include The Bill & Melinda Gates Foundation Trust.
Will Inventprise IPO soon?
No public IPO plans have been announced for Inventprise.
How can I track Inventprise secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inventprise's secondary market activity and sign up for updates.